March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
A Novel PRPF31 Mutation Causes Autosomal Dominant Retinitis Pigmentosa
Author Affiliations & Notes
  • Craig D. Beight
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio
  • Meghan J. Marino
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio
  • Elias I. Traboulsi
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio
    Ophthalmology, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio
  • Stephanie A. Hagstrom
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio
    Ophthalmology, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio
  • Footnotes
    Commercial Relationships  Craig D. Beight, None; Meghan J. Marino, None; Elias I. Traboulsi, None; Stephanie A. Hagstrom, None
  • Footnotes
    Support  NEI EY16072, Foundation Fighting Blindness and Research to Prevent Blindness
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 4572. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Craig D. Beight, Meghan J. Marino, Elias I. Traboulsi, Stephanie A. Hagstrom; A Novel PRPF31 Mutation Causes Autosomal Dominant Retinitis Pigmentosa. Invest. Ophthalmol. Vis. Sci. 2012;53(14):4572.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : PRPF31 is a core component of the U4/U6/U5 tri-snRNP complex which constitutes the pre-mRNA processing spliceosome. Over 50 different mutations have been reported in PRPF31 to cause autosomal dominant retinitis pigmentosa (ADRP), a clinically and genetically heterogeneous group of inherited retinal degenerations. A range of phenotypic characteristics as well as incomplete penetrance is common in families carrying PRPF31 mutations. We report a novel mutation in this gene in multiple members of a Caucasian USA family.

Methods: : Direct genomic sequencing of the entire PRPF31 coding region and flanking intronic sequences was performed. Clinical findings in the proband and her siblings were reviewed.

Results: : The proband presented at the age of 41 years with a diagnosis of ADRP. Her nyctalopia started in her 20s and peripheral vision loss in the 30s. An ERG was performed at the age of 24 and showed severely reduced scotopic and photopic responses. At her latest visit, visual acuity (VA) was 20/25 OU with a myopic correction. Her color vision was normal. There were peripheral ring scotomas in both eyes. Ophthalmoscopy showed changes typical of RP and myopia. Genetic testing at a CLIA certified laboratory revealed a novel PRPF31 mutation, c.915_916insTGT (p.Val305_Asp306insCys). We confirmed the mutation in our laboratory and tested her two sisters ages 51 (VA 20/60 OD and 20/70 OS) and 52 (VA 20/200 OD and 20/400 OS); both sisters had typical RP and the older one had developed anterior and posterior uveitis, macular edema and cataracts. Both carried the identical mutation. Their father reportedly was totally blind from RP.

Conclusions: : We report a novel mutation in exon 9 of PRPF31 in a family with ADRP. The phenotype appears to consist of signs and symptoms that appear in the twenties and relentlessly progress with peripheral and central vision in the 50s. The association with uveitis in one family member is unclear.

Keywords: genetics • mutations • retinal degenerations: hereditary 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×